1,534 results on '"Fukunaga, Kohji"'
Search Results
2. GPR124 induces NLRP3 inflammasome-mediated pyroptosis in endothelial cells during ischemic injury
3. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice
4. Endocytosis of dopamine receptor: Signaling in brain
5. Propolis Promotes Memantine-Dependent Rescue of Cognitive Deficits in APP-KI Mice
6. Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and Disease
7. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications
8. BOD1 regulates the cerebellar IV/V lobe-fastigial nucleus circuit associated with motor coordination
9. Fatty acid-binding protein 7 triggers α-synuclein oligomerization in glial cells and oligodendrocytes associated with oxidative stress
10. Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy
11. Impaired Acquisition of Nicotine-Induced Conditioned Place Preference in Fatty Acid-Binding Protein 3 Null Mice
12. Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
13. T-type Ca2+ channel enhancer SAK3 administration improves the BPSD-like behaviors in AppNL−G-F/NL−G-F knock-in mice
14. Gut-brain axis: A matter of concern in neuropsychiatric disorders…!
15. Endothelial peroxynitrite causes disturbance of neuronal oscillations by targeting caspase-1 in the arcuate nucleus
16. Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling
17. Autism spectrum disorder (ASD): Disturbance of the melatonin system and its implications
18. Analysis of binding affinity and docking of novel fatty acid-binding protein (FABP) ligands
19. FABP7 Regulates Acetyl-CoA Metabolism Through the Interaction with ACLY in the Nucleus of Astrocytes
20. Nicotine Rescues Depressive-like Behaviors via α7-type Nicotinic Acetylcholine Receptor Activation in CaMKIV Null Mice
21. Feasibility and considerations of epsin2 as a candidate target for multiple system atrophy treatment
22. Use of melatonin for the treatment of dementia: Addressing core symptoms and behavioral challenges
23. Using Fatty Acid-Binding Proteins as Potential Biomarkers to Discriminate between Parkinson’s Disease and Dementia with Lewy Bodies: Exploration of a Novel Technique
24. Pharmacological inhibition of FABP7 by MF 6 counteracts cerebellum dysfunction in an experimental multiple system atrophy mouse model
25. Kir6.1 Heterozygous Mice Exhibit Aberrant Amygdala-Dependent Cued Fear Memory
26. Neuroprotection of SAK3 on scopolamine-induced cholinergic dysfunction in human neuroblastoma SH-SY5Y cells
27. Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference
28. Functional coupling of Tmem74 and HCN1 channels regulates anxiety-like behavior in BLA neurons
29. SAK3-Induced Neuroprotection Is Mediated by Nicotinic Acetylcholine Receptors
30. Cognitive enhancer ST101 improves schizophrenia-like behaviors in neonatal ventral hippocampus-lesioned rats in association with improved CaMKII/PKC pathway
31. Combined citicoline and docosahexaenoic acid treatment improves cognitive dysfunction following transient brain ischemia
32. Alzheimer's disease therapeutic candidate SAK3 is an enhancer of T-type calcium channels
33. T-type calcium channel enhancer SAK3 produces anti-depressant-like effects by promoting adult hippocampal neurogenesis in olfactory bulbectomized mice
34. Pathogenic Impact of Fatty Acid-Binding Proteins in Parkinson's Disease—Potential Biomarkers and Therapeutic Targets.
35. 神経可塑性を調節する認知症治療薬開発
36. Stimulation of the Sigma-1 Receptor and the Effects on Neurogenesis and Depressive Behaviors in Mice
37. Aberrant Amygdala-Dependent Cued Fear Memory in Na+/Ca2+ Exchanger 1 Heterozygous Mice
38. The T-type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation
39. Novel spiroimidazopyridine derivative SAK3 improves methimazole-induced cognitive deficits in mice
40. Epsin2, a novel target for multiple system atrophy therapy via α-synuclein/FABP7 propagation
41. Amelioration of Nicotine-Induced Conditioned Place Preference Behaviors in Mice by an FABP3 Inhibitor
42. Protein Kinases and Neurodegenerative Diseases
43. α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
44. Sigma-1 receptor is involved in modification of ER-mitochondria proximity and Ca2+ homeostasis in cardiomyocytes
45. Fatty acid-binding proteins 3 and 5 are involved in the initiation of mitochondrial damage in ischemic neurons
46. Endothelium-derived semaphorin 3G attenuates ischemic retinopathy by coordinating [beta]-catenin-dependent vascular remodeling
47. Combination of NAD+ and NADPH Offers Greater Neuroprotection in Ischemic Stroke Models by Relieving Metabolic Stress
48. Targeting G-quadruplex DNA as cognitive function therapy for ATR-X syndrome
49. Reduced CaM Kinase II and CaM Kinase IV Activities Underlie Cognitive Deficits in NCKX2 Heterozygous Mice
50. Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.